Suppr超能文献

开发和验证用于检测淋病奈瑟菌抗原的鼠和人 IgG 和 IgA 的多重分析方法。

Development and Validation of Multiplex Assays for Mouse and Human IgG and IgA to Neisseria gonorrhoeae Antigens.

机构信息

Duke Human Vaccine Institute, Department of Medicine, School of Medicine, Duke University, Durham, North Carolina.

Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

出版信息

J Infect Dis. 2024 Oct 16;230(4):852-856. doi: 10.1093/infdis/jiae153.

Abstract

There is an urgent need for vaccines against Neisseria gonorrhoeae, the causative agent of gonorrhea. Vaccination with an outer membrane vesicle-based Neisseria meningitidis vaccine provides some protection from N. gonorrhoeae; however, the mechanisms underlying this cross-protection are unknown. To address this need, we developed multiplexed bead-based assays for the relative quantification of human and mouse IgG and IgA against N gonorrhoeae antigens. The assays were evaluated for analyte independence, dilutional linearity, specificity, sensitivity, intra- and interassay variability, and robustness to sample storage conditions. The assay was then used to test samples from mice and humans immunized with an N meningitidis outer membrane vesicle vaccine.

摘要

目前迫切需要针对淋病奈瑟菌(导致淋病的病原体)的疫苗。接种脑膜炎奈瑟菌外膜囊泡疫苗可提供针对淋病奈瑟菌的一定程度的保护;然而,这种交叉保护的机制尚不清楚。为满足这一需求,我们开发了基于多重珠粒的分析方法,用于相对定量针对淋病奈瑟菌抗原的人源和鼠源 IgG 和 IgA。评估了分析方法的分析物独立性、稀释线性、特异性、灵敏度、批内和批间变异性以及对样品储存条件的稳健性。然后,使用该方法检测了接种脑膜炎奈瑟菌外膜囊泡疫苗的小鼠和人类的样本。

相似文献

2
The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.
PLoS Pathog. 2020 Dec 8;16(12):e1008602. doi: 10.1371/journal.ppat.1008602. eCollection 2020 Dec.
3
Antibody tests for identification of current and past infection with SARS-CoV-2.
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
4
Review of mathematical models of Neisseria gonorrhoeae vaccine impact: Implications for vaccine development.
Vaccine. 2024 Jul 25;42(19S1):S70-S81. doi: 10.1016/j.vaccine.2024.03.068. Epub 2024 Mar 30.
5
Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae.
Ann Intern Med. 2005 Jun 7;142(11):914-25. doi: 10.7326/0003-4819-142-11-200506070-00010.
7
antimicrobial susceptibility testing: application of traditional agar dilution to a high-throughput 96-well microtiter assay.
Microbiol Spectr. 2025 Jul;13(7):e0324924. doi: 10.1128/spectrum.03249-24. Epub 2025 Jun 9.
8
The potential impact of a vaccine on Neisseria gonorrhoeae prevalence among heterosexuals living in a high prevalence setting.
Vaccine. 2023 Aug 31;41(38):5553-5561. doi: 10.1016/j.vaccine.2023.07.048. Epub 2023 Jul 28.
10
The gonococcal vaccine candidate antigen NGO1701 is a periplasmic copper storage protein.
bioRxiv. 2025 May 7:2025.05.01.651437. doi: 10.1101/2025.05.01.651437.

本文引用的文献

1
Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study.
Lancet Infect Dis. 2022 Jul;22(7):1021-1029. doi: 10.1016/S1473-3099(21)00812-4. Epub 2022 Apr 12.
2
Product review on the IMD serogroup B vaccine Bexsero®.
Hum Vaccin Immunother. 2022 Dec 31;18(1):2020043. doi: 10.1080/21645515.2021.2020043. Epub 2022 Feb 22.
4
The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.
PLoS Pathog. 2020 Dec 8;16(12):e1008602. doi: 10.1371/journal.ppat.1008602. eCollection 2020 Dec.
7
Human Immune Responses and the Natural History of Infection.
Front Immunol. 2019 Feb 19;9:3187. doi: 10.3389/fimmu.2018.03187. eCollection 2018.
8
Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study.
Lancet. 2017 Sep 30;390(10102):1603-1610. doi: 10.1016/S0140-6736(17)31449-6. Epub 2017 Jul 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验